Profile
Mr. Gary Cohen is Secretary, Senior Vice President & General Counsel at Knome, Inc.
Mr. Cohen was previously employed as Chief-Medical Oncology by Mercy Health System Corp., a Director-Medical Breast Services by University of California, Davis, a Principal by Amgen, Inc., a Principal by Kosan Biosciences, Inc., Vice President & General Counsel by Genzyme Transgenics Corp, and Vice President-Medical Affairs by Genomic Health, Inc.
He received his undergraduate degree from Washington University in St. Louis, a graduate degree from Boston University, and a graduate degree from Columbia Law School.
Former positions of Gary Cohen
| Companies | Position | End |
|---|---|---|
| University of California, Davis | Corporate Officer/Principal | - |
Mercy Health System Corp.
 Mercy Health System Corp. Hospital/Nursing ManagementHealth Services Mercy Health System Corp. engages in the operations of regional health systems of hospitals, clinics, and specialty care centers. Its services include orthopedic surgery; pre-hospital emergency services and training; neurosurgery; heart and vascular; cancer care; and plastic and reconstructive surgery. The company was founded in 1895 and is headquartered in Janesville, WI. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| GENOMIC HEALTH, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Gary Cohen
| Washington University in St. Louis | Undergraduate Degree |
| Boston University | Graduate Degree |
| Columbia Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 5 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Tafkak, Inc.
 Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA. | Commercial Services |
Mercy Health System Corp.
Mercy Health System Corp. Hospital/Nursing ManagementHealth Services Mercy Health System Corp. engages in the operations of regional health systems of hospitals, clinics, and specialty care centers. Its services include orthopedic surgery; pre-hospital emergency services and training; neurosurgery; heart and vascular; cancer care; and plastic and reconstructive surgery. The company was founded in 1895 and is headquartered in Janesville, WI. | Health Services |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
- Stock Market
- Insiders
- Gary Cohen
